Log in
NASDAQ:SIBN

SI-Bone Stock Forecast, Price & News

$23.32
+0.33 (+1.44 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$22.73
Now: $23.32
$23.58
50-Day Range
$17.48
MA: $21.47
$24.28
52-Week Range
$7.20
Now: $23.32
$25.31
Volume141,125 shs
Average Volume226,592 shs
Market Capitalization$667.65 million
P/E RatioN/A
Dividend YieldN/A
Beta1.46
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.09 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.30 million
Book Value$2.52 per share

Profitability

Net Income$-38,400,000.00

Miscellaneous

Employees183
Market Cap$667.65 million
Next Earnings Date11/9/2020 (Estimated)
OptionableNot Optionable
$23.32
+0.33 (+1.44 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

How has SI-Bone's stock price been impacted by COVID-19 (Coronavirus)?

SI-Bone's stock was trading at $15.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SIBN shares have increased by 52.2% and is now trading at $23.32.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of SI-Bone?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for SI-Bone
.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for SI-Bone
.

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) announced its quarterly earnings data on Monday, August, 3rd. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.64) by $0.20. The company had revenue of $14.05 million for the quarter, compared to the consensus estimate of $9.48 million. SI-Bone had a negative net margin of 68.27% and a negative return on equity of 51.27%.
View SI-Bone's earnings history
.

What price target have analysts set for SIBN?

6 analysts have issued 12-month price targets for SI-Bone's shares. Their forecasts range from $22.00 to $27.00. On average, they expect SI-Bone's share price to reach $24.50 in the next year. This suggests a possible upside of 5.1% from the stock's current price.
View analysts' price targets for SI-Bone
.

Are investors shorting SI-Bone?

SI-Bone saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 404,800 shares, a drop of 60.7% from the August 15th total of 1,030,000 shares. Based on an average daily volume of 200,100 shares, the short-interest ratio is presently 2.0 days. Approximately 1.9% of the company's stock are sold short.
View SI-Bone's Short Interest
.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Who are SI-Bone's key executives?

SI-Bone's management team includes the following people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Gilder Gagnon Howe & Co. LLC (4.70%), Vanguard Group Inc. (4.34%), Driehaus Capital Management LLC (3.92%), First Light Asset Management LLC (2.34%), Silvercrest Asset Management Group LLC (0.97%) and Charles Schwab Investment Management Inc. (0.51%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling.
View institutional ownership trends for SI-Bone
.

Which major investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Silvercrest Asset Management Group LLC, Columbus Circle Investors, First Light Asset Management LLC, and UBS Group AG. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp, and W Carlton Reckling.
View insider buying and selling activity for SI-Bone
.

Which major investors are buying SI-Bone stock?

SIBN stock was purchased by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Goldman Sachs Group Inc., Swiss National Bank, Gilder Gagnon Howe & Co. LLC, Bank of New York Mellon Corp, Bank of America Corp DE, Charles Schwab Investment Management Inc., and Nuveen Asset Management LLC. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita, and Skyline Venture Partners V Lp.
View insider buying and selling activity for SI-Bone
.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $23.32.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $667.65 million and generates $67.30 million in revenue each year. The company earns $-38,400,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. SI-Bone employs 183 workers across the globe.

What is SI-Bone's official website?

The official website for SI-Bone is www.si-bone.com.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.